Our previous research showed that the downregulation of TA-MUC1 is capable of modulating calcium cellular effects via alteration in the expression of calcium signalling proteins and by impacting calcium-induced initiation of procoagulant activity, which is capable of influencing the effect of thrombin on cancer cells as well [6]. Here, MUC1 is linked to cancer.